We recently published 10 Stocks Losing Their Bite Before Thanksgiving. Super Group (SGHC) Limited (NYSE:SGHC) is one of the worst-performing stocks on Wednesday. Super Group dropped its share prices by 6.74 percent on Wednesday to close at $10.93 apiece as investor sentiment was dampened by the United Kingdom’s decision to slap higher duties on gambling activities. Effective April 2026, the new rules would raise the taxes on remote gaming to 40 percent from 21 percent previously, while in April 2027, lev ...

Airlines stocks have overcome severe turbulence in 2025 to fly into positive territory. But there's more trouble ahead and the sector needs a strong holiday travel period to hold on to its gains. ...

Key Takeaways Tech stocks rebound as investors eye a December rate cut and four large-cap picks gain focus.Softer PPI and retail sales data boost hopes for easing and support renewed interest in NVDA.PLTR posts rising earnings estimates, highlighting strong growth expectations across the tech group.Wall Street appears to have rebounded after a tech bloodbath saw all major indexes — the S&P 500, the Nasdaq and the Dow — remain volatile in October and November. However, tech stocks are once again driving the ...

Key Takeaways Oklo advances its Aurora microreactor plans but faces volatility, permitting challenges and no revenues.D's nuclear fleet, turnaround progress and major capex plans support steadier long-term growth visibility.Price, valuation and earnings trends show D with more stability. Oklo remains a risky early-stage play.Oklo Inc. ((OKLO) and Dominion Energy ((D) are two very different companies. Yet, they share a meaningful common thread: both are tied to the expanding role of nuclear power in a world ...

TORONTO, Nov. 27, 2025 (GLOBE NEWSWIRE) -- CF Energy Corp. (TSX-V: CFY) (“CF Energy” or the “Company”, together with its subsidiaries, the “Group”), an energy provider in the People’s Republic of China (the ”PRC” or “China”), announces that the Company has filed its unaudited interim consolidated financial results for the three-month and nine-month periods ended September 30, 2025. The unaudited condensed interim consolidated financial statements and Management’s Discussion and Analysis (“MD&A”) can be down ...

Taking another look at Vistra ( VST ). My view hasn’t changed since the last time . The stock has dropped over 10% since August, from $197 to about $176. That’s after people pushed the price up to an all-time highWith over 15 years of experience in the markets and a degree in economics, I focus on breaking down companies with clarity and discipline. My goal is to give individual investors a straightforward, honest view—what’s working, what isn’t, and where the risks and opportunities actually are. I don’t c ...

If you want full access to all our reports, data and investing ideas, join The Aerospace Forum , the #1 aerospace, defense and airline investment research service on Seeking Alpha, with access to evoX Data Analytics, our in-house developed data analytics platform.Dhierin-Perkash Bechai is an aerospace, defense and airline analyst. Dhierin runs the investing group The Aerospace Forum, whose goal is to discover investment opportunities in the aerospace, defense and airline industry. With a background in aeros ...

I am a dynamic finance professional with a Master’s in Banking & Finance from Université Paris 1 Panthéon-Sorbonne. My investing background mix corporate finance, M&A, and investment analysis, with a focus on real estate, renewable energy, and equity markets. I specialize in financial modelling, valuation, and qualitative analysis, demonstrated with hands-on roles in private equity, asset management and Real Estate. On Seeking Alpha, I aim to write about companies I find interesting sharing my insights and ...

Key Takeaways Salesforce expects Q3 revenues of $10.24-$10.29 billion vs. the consensus estimate of $10.26 billion.CRM projects Q3 EPS of $2.84-$2.86 vs. the consensus estimate of $2.85.Generative AI demand, acquisitions and cost cuts are likely to boost Salesforce's results.Salesforce (CRM) is scheduled to release third-quarter fiscal 2026 results on Dec. 3.For the fiscal third quarter, the company expects total revenues between $10.24 billion and $10.29 billion (midpoint at $10.265 billion). The Zacks Con ...

Key Takeaways BEAM and NTLA are compared as gene editing biotechs with pipelines at different development stages.BEAM advances multiple SCD programs and updates its BEAM-101 and BEAM-301 studies across phases.NTLA pushes late-stage in vivo candidates while a clinical hold on nex-z raises safety concerns.Beam Therapeutics (BEAM) and Intellia Therapeutics (NTLA) are clinical-stage companies developing investigational gene therapies. While BEAM’s pipeline candidates are still in early-stage development, NTLA i ...